Barbara Sue Wendland, NP

Barbara Wendland practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Barbara Wendland's NPI, 1508943358, was assigned on November 1, 2006. Barbara Wendland holds California license 6098.

Barbara Wendland's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Barbara Wendland's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is UCSF Medical Group. Dmand AI also links Barbara Wendland to 1 more hospital and 3 medical groups, each named with a free account. Barbara Wendland's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Barbara Wendland practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Barbara Wendland's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Barbara Wendland is licensed in California.

CMS counts 126 Medicare patients who saw Barbara Wendland in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 27% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Barbara Wendland's median patient age at 59, with 68% women.

In 2024, Barbara Wendland wrote 32 Medicare Part D claims for 21 patients. 78% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Barbara Wendland for performance year 2024, reported as part of a group. Barbara Wendland accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 10 general payments to Barbara Wendland from 8 drug and device companies in 2025. Food and beverage make up the largest share, 84% of the total. AstraZeneca Pharmaceuticals LP paid the most, $72.